Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endovascular Treatment of Thoracic Aortic Disease

NCT00583817 is registered in ClinicalTrials.gov with Matthew Eagleton as lead sponsor.

NCT NCT00583817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00583817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endovascular Treatment of Thoracic Aortic Disease
Lead sponsor
Matthew Eagleton
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
October 25, 2018
Completion date
December 31, 2030
Enrollment
170 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aortic arch; aneurysm, dissecting, aortic dissection, ascending aorta aneurysm, ascending aortic dissection, dissecting, aneurysm, renal artery aneurysm, superior mesenteric artery aneurysm, thoracic aortic aneurysms, thoracoabdominal aortic aneurysm